Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
287714-30-1287714-30-1VerwendenTreatment of intestinal diseases characterized by chemical or surgical damage of the intestinal epithelium such as Short Bowel Syndrome (SBS) or damage to the intestinal epithelium due to disease (glucagon-like peptide-2 (GLP- 2) analog).